IMPACT OF EGFR MUTATION ON PROGNOSIS OF STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER NSCLC: A RETROSPECTIVE ANALYSIS
Background: Patients with activating somatic mutations in the Epidermal Growth Factor Receptor (EGFR) have better prognosis when treated with Tyrosine Kinase Inhibitors (TKI) as the standard treatment of care in advanced stage NSCLC.Aim of the work: To study the impact of EGFR mutation on prognosis...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Ain Shams University; Faculty of Medicine. Ain Shams Clinical and Scientific Society
2023-06-01
|
| Серія: | Ain Shams Medical Journal |
| Предмети: | |
| Онлайн доступ: | https://asmj.journals.ekb.eg/article_307098_fc9aac9b0d5f6c6b551e314d913941be.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|